Dry AMD is a slow process of vision loss and is not currently treatable, whereas wet AMD is a rapid deterioration of vision, partially treatable by injections of anti-vascular endothelial growth factor (anti-VEGF) into the affected eye [3]. Here, VEGFA is linked to wet macular degeneration.